General Information of Drug (ID: DM6FKOW)

Drug Name
MG-4101
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
Cross-matching ID
TTD ID
D0F4UM

References

1 ClinicalTrials.gov (NCT02008929) to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell). U.S. National Institutes of Health.